Another limitation of the studies was the use of different comparators ranging from placebo controls to other medications for T2DM (including insulin), which have different effects on bone tissue and were included in only one group, misleading the interpretation
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
So I think that what were missing in the whole discussion is thinking about how do we ramp up mitochondrial energy production, how do we prevent it from declining and aging so that the body, so that the brain can rightly perceive that I am in a state of abundance
According to electronic health record data from Cleveland Clinic published in the Journal of Diabetes and Its Complications in 2023, urine protein assessments were completed for 7.6% of adults with CKD, 30.2% of those with CKD and type 2 diabetes and 20.1% of adults with type 2 diabetes in 2019